Moroder L - Search Results

1

Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity.

Banke IJ, Arlt MJ, Mueller MM, Sperl S, Stemberger A, Stürzebecher J, Amirkhosravi A, Moroder L, Krüger A. Banke IJ, et al. Among authors: moroder l. Thromb Haemost. 2005 Nov;94(5):1084-93. doi: 10.1160/TH05-04-0249. Thromb Haemost. 2005. PMID: 16363253

2

(R)-3-Amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode.

Mueller MM, Sperl S, Stürzebecher J, Bode W, Moroder L. Mueller MM, et al. Among authors: moroder l. Biol Chem. 2002 Jul-Aug;383(7-8):1185-91. doi: 10.1515/BC.2002.130. Biol Chem. 2002. PMID: 12437104

3

Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.

Sperl S, Bergner A, Stürzebecher J, Magdolen V, Bode W, Moroder L. Sperl S, et al. Among authors: moroder l. Biol Chem. 2000 Apr;381(4):321-9. doi: 10.1515/BC.2000.042. Biol Chem. 2000. PMID: 10839461

4

Design of benzamidine-type inhibitors of factor Xa.

Gabriel B, Stubbs MT, Bergner A, Hauptmann J, Bode W, Stürzebecher J, Moroder L. Gabriel B, et al. Among authors: moroder l. J Med Chem. 1998 Oct 22;41(22):4240-50. doi: 10.1021/jm980227t. J Med Chem. 1998. PMID: 9784099

5

(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.

Sperl S, Jacob U, Arroyo de Prada N, Stürzebecher J, Wilhelm OG, Bode W, Magdolen V, Huber R, Moroder L. Sperl S, et al. Among authors: moroder l. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5113-8. doi: 10.1073/pnas.97.10.5113. Proc Natl Acad Sci U S A. 2000. PMID: 10805774 Free PMC article.

6

The uPA/uPA receptor system as a target for tumor therapy.

Sperl S, Mueller MM, Wilhelm OG, Schmitt M, Magdolen V, Moroder L. Sperl S, et al. Among authors: moroder l. Drug News Perspect. 2001 Sep;14(7):401-11. doi: 10.1358/dnp.2001.14.7.858423. Drug News Perspect. 2001. PMID: 12813583

7

The persisting challenge of selective and specific proteasome inhibition.

Groll M, Huber R, Moroder L. Groll M, et al. Among authors: moroder l. J Pept Sci. 2009 Feb;15(2):58-66. doi: 10.1002/psc.1107. J Pept Sci. 2009. PMID: 19109822 Review.

8

Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.

Gil-Parrado S, Assfalg-Machleidt I, Fiorino F, Deluca D, Pfeiler D, Schaschke N, Moroder L, Machleidt W. Gil-Parrado S, et al. Among authors: moroder l. Biol Chem. 2003 Mar;384(3):395-402. doi: 10.1515/BC.2003.045. Biol Chem. 2003. PMID: 12715890 Free article.

9

A new cell-permeable calpain inhibitor.

Fiorino F, Gil-Parrado S, Assfalg-Machleidt I, Machleidt W, Moroder L. Fiorino F, et al. Among authors: moroder l. J Pept Sci. 2007 Jan;13(1):70-3. doi: 10.1002/psc.790. J Pept Sci. 2007. PMID: 17019744

10

Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).

Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L. Graf von Roedern E, et al. Among authors: moroder l. J Med Chem. 1998 Jul 30;41(16):3041-7. doi: 10.1021/jm980112p. J Med Chem. 1998. PMID: 9685244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters